Skip to main content
Back to CRV

CRV's Therapeutics Portfolio

Browse 3 Therapeutics companies funded by CRV. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
3
Total Funding in Therapeutics
$137.1M

Therapeutics Portfolio Companies (3)

Export
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

San Diego, United States
August 2025
$60.1M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Switch Therapeutics is a biotech company that develops RNAi therapies.

San Francisco, United States
March 2023
$52.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyNeuroscienceTherapeutics

System1 Biosciences is a neurotherapeutics company.

San Francisco, United States
September 2018
$25.0M
Series A

Founder Contacts

41,000+ verified contacts

Explore CRV's Full Portfolio

View all companies funded by CRV across every industry and funding stage.

View Full CRV Portfolio